| « Previous month | Next month » |
Plexera Biosciences is hoping to leave its rivals in its wake following an exclusive option agreement for Auguron Biosciences' DNA-based protein chips.
Administrators are now trying to sell Jaycare, a UK custom manufacturer and supplier of rigid plastic packaging, medical devices and technical componentry to the pharma and healthcare industries, which has gone bust.
Disease treatments could be developed faster thanks to a new mathematical model that calculates how popular a protein is in terms of how likely another protein will want to associate with it.
Becton Dickinson has reported first quarter earnings that nearly doubled year-on-year - with sales driven on by the weak American currency and outweighing increased operating costs.
Clontech Laboratories is about to release its ProteoTuner System which can regulate the amount of protein in a cell and ought to be a powerful tool to analyse a protein's function.
A controversial new theory on the origins of Alzheimer's has divided opinion in the medical world, but if proved right could 'revolutionise' treatment.
PerkinElmer post a 26 per cent rise in its Q4 profits, boosted by its laboratory and diagnostic equipment sales and confounding Wall Street expectations in the process. The company also expect 2008 first-quarter profit to top analyst estimates.
In any laboratory, or indeed in any pharmaceutical manufacturing facility, one of the major expenses will be solvents. And just like the price of petrol and diesel it just keeps going up and up. Huw Kidwell examines how a new recycling approach could keep costs down and help protect the environment to boot.
Laboratory Corp has announced its intention to buy fellow US lab services firm Tandem Labs for an undisclosed sum.
WaferGen has launched a new subsidiary in Kedah, Malaysia, with the express purpose of overseeing research and development of its real-time PCR system.
Labcyte and Deerac Fluidics, which both make liquid handling devices, albeit for different low-volume ranges, have decided to merge and combine their technologies.
Thermo Fisher Scientific aims to make automation in the drug discovery lab a whole lot easier through the development of an articulated robot specifically designed for pharmaceutical applications.
Google funded start up, 23andme, has now launched its gene tests and web-based analysis in Canada and Europe.
Applied Biosystems has initiated a collaboration with Mettler Toledo with the intention of integrating their lab management software applications.
Tecan and PerkinElmer have taken the opportunity to showcase new plate reader products at LabAutomation 2008, firmly re-establishing themselves as major players in this popular and lucrative sector.
US scientists have found a way of stopping quantum dots from 'blinking'. The resultant increase in light intensity could make them more useful in medical research.
Australia-based Invetech has committed itself to tackling the US market, opening up its first facility in the country - home of the world's largest drug industry.
Vapourtec has made two new additions to its Flow Chemistry platform available as the company make headway in an emerging field, which aims to speed up laboratory processes in drug discovery.
An international consortium has begun an ambitious project to sequence the complete genomes of at least 1,000 people in order to learn more about the effect of genetics on disease.
The world's most powerful transmission electron microscope has been turned on in the US, with single-atom resolution bringing within reach the ability to analyse chemicals simply by looking at them.
Beckman Coulter has launched a four-year collaboration with Irish University NUI Galway in the hope of speeding up molecular diagnostic tests.
Australian firm Fluorotechnics wants to bolster the sales of its proteomics products in Japan and so has signed up Osaka firm Wako Pure Chemical Industries to help.
After seven months of offers, refusals and heated exchanges, it seems an increased offer from Roche has finally persuaded the powers that be at Ventana to sell up.
GE Healthcare has reported its fourth quarter and full year financial results in a tough 12 months that have seen the laboratory imaging and diagnostics company feel the full force of US Government regulatory pressure.
LabTechnologist.com brings you a round up of recent industry news, with developments at Activotec, Protagen, Caprotec Bioanalytics and PANalytical.
In this week's review of activity within the preclinical research services arena, news has emerged involving Galapagos, Argenta Discovery and ChemDiv.
LabTechnologist.com brings you a round up of the latest product news and releases from Lonza, MIP Technologies and Supelco, Illumina, Cisbio, Bookham and Tecan.
Scientists have discovered a technique that can ensure lab samples stay at the right pH, even when frozen and the discovery could bring into doubt previously published research.
New UK Government proposals to scrap Capital Gains Tax (CGT) relief will stifle life science innovation, according to a group of biotech small and medium enterprises (SMEs).
The European Commission has launched an investigation into the entire European pharmaceutical sector, with surprise raids on a number of manufacturers in a bid to unearth any evidence of foul-play hampering the launch of new medicines on the market.
Wyeth's manufacturing facility in Rouses Point, New York, has been spared the scrap heap, with yesterday's announcement that new pharma player Akrimax has bought up the beleaguered site.
Pfizer Japan is cleaning out its closet, selling a range of its "surplus" biotech and pharmaceutical lab equipment via an online auction, a method that is slowly catching on in the country.
The Biotechnology Industry Organization has fired a broadside at French President Nicolas Sarkozy after he banned a GM corn crop without, it says, 'any scientific basis'.
Invitrogen has splashed the cash on a manufacturer of liver cell products that can be used to test a drug's potential toxicity and so avoid costly clinical failures.
UK separation technology specialists Whatman has confirmed it has received a number of preliminary approaches for the firm, sending its shares rocketing up.
Thousands of rodents lives will be saved each year after a specific animal test is being scrapped following a review by 18 pharmaceutical companies.
LabTechnologist.com brings you a round up of recent industry news, with developments at Advanced Cell Technology and Qiagen, Gene Bridges, Evotec and BioTek Instruments.
Diagnostics firm bioMérieux has announced plans to shift activities at its facility in the Netherlands to France, shutting down the Dutch site as it continues to haemorrhage cash.
How do you build on what has been dubbed the 'scientific breakthrough of 2007'? Affymetrix believes it has the answer with its next-gen arrays.
US firms Multispan and Promega have paired up to develop assay tools for G-protein coupled receptor (GPCR) screening, in the hope of speeding up drug discovery on these, the most popular protein targets in pharma.
Skin cancer detection specialists DermTech have decided to turn their hand to acne after signing an agreement with Stiefel Laboratories to identify spot-causing genes.
LabTechnologist.com brings you a round up of the latest product news and releases from Millipore, Gen-Probe, WaferGen, Beckman Coulter, Lab M, Labcyte, NuGen Technologies and PerkinElmer.
Applied Biosystems (ABI) has teamed up with several service providers to increase scientists' access to its SOLiD genome analysis system and hopefully save them some money.
Equipment manufacturing is one of the keys to helping India swell its portion of the global pharma pie, according to a new report from KPMG, so long as the sector does not remain so fragmented.
A Dutch developer has pulled out of a €60m project to build a science park in the country after it was "continually confronted" by animal rights extremists.
UK's NextGen Sciences and US firm Paragon Bioservices have heralded the formation of a new alliance to jointly offer each others services, as have Argenta Discovery and NeuroSolutions who are also now working together in the preclinical arena.
Numerous lives could be saved by a new blood test that can identify MRSA within two hours, instead of as many days, following its approval by the US Food and Drug Administration (FDA).
WuXi PharmaTech, China's contract research titan, has orchestrated its first acquisition, gaining biologics capabilities and a base in the US.
Barriers to innovation and technology transfer must be lowered if the US is to continue being a global leader in nanotechnology research and development in the future.
A group of US researchers have developed a new computer model to study and design miniature biosensors, which could help life scientists perfect lab-on-a-chip technology.
A new technique that allows scientists to visualise protein dynamics in live cell cultures could help scientists fish out specific rare cells out of a sea of clones.
Galapagos' services arm has scored another lucrative contract from big pharma - its first in the field of oncology - as it continues to broaden its experience.
| « Previous month | Next month » |